3. INTRO
Named after French venerologist
Jean Alfred Fournier in 1883 as a polymicrobial
infection of the genitals
Fourniers gangrene is a synergistic polymicrobial
necrotizing fasciitis of the perineum and genitalia
It’s a surgical emergency
2/15/2023 3
16. Most Common causative
organisms
Anaerobes; Bacteriodes fragilis,C-Perfringens,
peptococcus
Gram negative; E-coli, klep-pneumo,psedomo,p-
mirabilis
Gram positive; Staph aures and epidermidis, B-hemol
strep and strep feacalis,
Mycobacterium TB
Yeast; C-A
2/15/2023 16
17. Pathogenesis
The pathogenesis of fourniers is characterized by poly
microbial infection with subsequent vascular
thrombosis and tissue necrosis aggravated by poor
host defence due to one or more systemic disorders
Aerobic organisms causes intravascular coagulation by
inducing platelet aggregation and complement
fixation while anaerobes produce heparinase
2/15/2023 17
18. Hypoxic tissue leads to the formation of oxygen free
radicals(HO,H2O2,)
Leading to cell membrane disruption and decreased
ATP production and DNA damage which leads to
decrease protein production
2/15/2023 18
19. Anaerobic organisms secrete various enzymes and
toxins-lecithinase,collagenase and hyaluronidase
which digest fascia planes
They produce insoluble hydrogen and nitrogen
leading to formation of gas in sucutaneuos tissue
clinically palpated as crepitus
2/15/2023 19
20. Endotoxins are released from cell wall of gram
negatives bacteria
Macrophages activation and subsequent complement
activation ensues with release of pro-inflammatory
cytokines and eventual development of septic shock
2/15/2023 20
21. Clinical Presentation
Prodromal; fever and lethargy , 2-7days
Intense genital pain and tenderness with edema of
overlying skin
Increasing genital pain with erythema of overlying
skin
Dusky appearance of overlying skin and subcutaneous
crepitation
Obvious gangrene +-purulent drainage
2/15/2023 21
30. Prognosis
In the pre- antibiotic era, fourniers gangrene was
commonly fatal; even today it poses a significant risk
of morbidity and mortality
Despite aggressive therapy, the mortality rate ranges
from 25%-40% because of its aggressive nature and
presence of underlying comorbidities
2/15/2023 30